Sep 10, 2010 5:30pm PDT
access to skilled psychiatrists, not enough psychotherapy. >> suarez: doctor stephen stahl is an expert in the use of medications for treating mental illness. >> i think that there is a crisis in the delivery of mental health care in the army. i think the overall care that the soldiers were getting for psychological wounds was substandard. >> suarez: a year and a half ago, dr. stahl taught health care providers at fort hood the latest in best practices. just months later, army psychiatrist major nidal hasan allegedly went on a shooting rampage, killing 13 and wounding dozens more. in the aftermath of the killings, it was reported that major hasan was kept on staff in spite of concerns about his abilities because there are so few psychiatrists in the army. dr. stahl says that, while they are understaffed, they are doing heroic work. he says the 34 psychiatrists, psychologists and other counselors at the base are overwhelmed by the demand for their services. besides treating the soldiers in the transition brigade, they also have to provide services to 50,000 to 60,000 other soldiers and t
Sep 10, 2010 7:00pm PDT
. stephen elop takes over as c.e.o. later this month. he was the head of microsoft's biggest division by sales, its business software unit. he takes over a company that sells more mobile phones than anyone else. in the second quarter, nokia's name was on more than one out of every three mobile phones. but, critics say, it is behind in the smartphone market. it is expected to answer critics next week with its n8 smartphone. it will be unveiled in london. one question is whether or not any u.s. carriers have signed on. shares were up 2% on three times its usual volume. the big drop in april came when nokia cut its profit outlook. the trio nokia is competing with for phone software is google, research in motion and apple. tech consultant firm gartner thinks google's android phone software will be the second biggest by the end of this year. nokia remains the biggest. this threesome made fractional moves today. and, the f.d.a. o.k. for a return to the market of a potassium drug provided for some big moves for its maker, k.v. pharmaceutical, and its competitor watson. k.v. rocketed up 74%.